Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29774450 | 1.00 | GAA (0.44) | GAAMAPT | |
| SCHEMBL29830729 | 0.78 | GAA (0.44) | GAAMAPT | |
| SCHEMBL34295 | 0.77 | GAA (0.48) | GAAMAPT | |
| SCHEMBL29415525 | 0.77 | GAA (0.48) | GAAMAPT | |
| SCHEMBL3104669 | 0.77 | GAA (0.37) | GAAMAPT | |
| SCHEMBL31079568 | 0.76 | GAA (0.39) | GAAMAPT | |
| SCHEMBL8489461 | 0.76 | GAA (0.46) | GAAMAPT | |
| SCHEMBL9683514 | 0.76 | GAA (0.46) | GAAMAPT | |
| Potassium SCHEMBL9683518 | 0.76 | GAA (0.46) | GAAMAPT | |
| Bromide SCHEMBL8857359 | 0.76 | GAA (0.46) | GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 445 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113861128-A | Polymerizable compound and optically anisotropic body | 江苏创拓新材料有限公司 | 2021-12-31 | — | — | CN | claimed |
| EP-2961411-A2 | METHODS OF TREATMENT OF HUMAN CYTOMEGALOVIRUS INFECTION AND DISEASES WITH BROMODOMAIN INHIBITORS | Washington University (US) | 2016-01-06 | — | — | EP | claimed |
| US-20150366877-A1 | METHODS OF TREATMENT OF HUMAN CYTOMEGALOVIRUS INFECTION AND DISEASES WITH BROMODOMAIN INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-12-24 | — | — | US | claimed |
| WO-2014134583-A2 | METHODS OF TREATMENT OF HUMAN CYTOMEGALOVIRUS INFECTION AND DISEASES WITH BROMODOMAIN INHIBITORS | WASHINGTON UNIVERSITY (US) | 2014-09-04 | — | — | WO | claimed |
| EP-1852420-B1 | Indole compounds for treating respiratory disorders | ONO PHARMACEUTICAL CO (JP) | 2012-10-17 | — | — | EP | claimed |
| US-8153625-B2 | Nitrogen-containing heterocyclic compounds and medicinal use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2012-04-10 | — | — | US | claimed |
| US-7759336-B2 | Nitrogen-containing heterocyclic compounds and medicinal use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2010-07-20 | — | — | US | claimed |
| US-20090233913-A1 | OPTICAL ISOMERS OF DIHYDRO-2,3-BENZODIAZEPINES AND THEIR STEREOSELECTIVE SYNTHESIS | EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENYTARSASAG (HU) | 2009-09-17 | — | — | US | claimed |
| CN-101389600-A | Optical isomers of dihydro-2, 3-benzodiazepine and its stereoselective synthesis | EGYT GYOGYSZERVEGYESZETI GYAR (HU) | 2009-03-18 | — | — | CN | claimed |
| EP-1979308-A1 | OPTICAL ISOMERS OF DIHYDRO-2,3-BENZODIAZEPINES AND THEIR STEREOSELECTIVE SYNTHESIS | EGIS Gyógyszergyár Nyrt (HU) | 2008-10-15 | — | — | EP | claimed |
| WO-2007077469-A1 | OPTICAL ISOMERS OF DIHYDRO-2,3-BENZODIAZEPINES AND THEIR STEREOSELECTIVE SYNTHESIS | EGIS GYÓGYSZERGYÁR (HU) | 2007-07-12 | — | — | WO | claimed |
| CN-1027505-C | Process for preparing benzoheterocyclic compounds | OTSUKA PHARMA CO LTD (JP) | 1995-01-25 | — | — | CN | claimed |
| JP-52065287-A | — | — | None | — | — | JP | disclosed |
| JP-52039690-A | — | — | None | — | — | JP | disclosed |
| US-12637436-B2 | Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof | Sanford Burnham Prebys Medical Discovery Institute (US) | 2026-05-26 | — | — | US | disclosed |
| US-12600730-B2 | Substituted cyclopenta[c]pyrroles as ABHD6 antagonists | ONO PHARMACEUTICAL CO., LTD. (JP) | 2026-04-14 | — | — | US | disclosed |
| JP-S5239690-A | PREPARATION OF BENZODIAZEPIN DERIVATIVES | SUMITOMO CHEM CO LTD | 1977-03-28 | — | — | JP | disclosed |
| US-4002611-A | Preparation of benzodiazepines | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-01-11 | — | — | US | disclosed |
| US-3875142-A | Process for preparing 2,3-dihydro-1H-benzodiazepine derivatives and their salts | SUMITOMO CHEMICAL CO | 1975-04-01 | — | — | US | disclosed |
| US-3875142-A | Process for preparing 2,3-dihydro-1H-benzodiazepine derivatives and their salts | SUMITOMO CHEMICAL CO | 1975-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090233913-A1 | OPTICAL ISOMERS OF DIHYDRO-2,3-BENZODIAZEPINES AND THEIR STEREOSELECTIVE SYNTHESIS | GABRA2, GABRA3, GABRB2 | GAA 2736/4885MAPT 1366/4885 |
| US-20150366877-A1 | METHODS OF TREATMENT OF HUMAN CYTOMEGALOVIRUS INFECTION AND DISEASES WITH BROMODOMAIN INHIBITORS | BRD4, BRD3, BRD2 | GAA 1938/4885MAPT 2659/4885 |
| US-12600730-B2 | Substituted cyclopenta[c]pyrroles as ABHD6 antagonists | ABHD6, ABHD16A, HDHD5 | GAA 1736/4885MAPT 4432/4885 |
| US-12637436-B2 | Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof | GRM3, GRM2, GRM1 | GAA 4282/4885MAPT 1612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.